Sabra Healthcare REIT (SBRA) Competitors

In the previous week, LTC Properties had 15 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 15 mentions for LTC Properties and 0 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.79 beat LTC Properties' score of 0.70 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 69.3% of LTC Properties shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by insiders. Comparatively, 2.2% of LTC Properties shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Sabra Healthcare REIT has higher revenue and earnings than LTC Properties. LTC Properties is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

LTC Properties has a net margin of 38.84% compared to Sabra Healthcare REIT's net margin of 7.61%. LTC Properties' return on equity of 11.42% beat Sabra Healthcare REIT's return on equity.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.3%. LTC Properties pays an annual dividend of $2.28 per share and has a dividend yield of 5.3%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. LTC Properties pays out 84.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Sabra Healthcare REIT has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, LTC Properties has a beta of 0.55, suggesting that its share price is 45% less volatile than the broader market.

Sabra Healthcare REIT currently has a consensus target price of $22.23, suggesting a potential upside of 16.03%. LTC Properties has a consensus target price of $46.50, suggesting a potential upside of 8.29%. Given Sabra Healthcare REIT's higher probable upside, equities research analysts plainly believe Sabra Healthcare REIT is more favorable than LTC Properties.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 62.5% of National Health Investors shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 2.7% of National Health Investors shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

In the previous week, National Health Investors had 10 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 10 mentions for National Health Investors and 0 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.79 beat National Health Investors' score of 0.40 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.3%. National Health Investors pays an annual dividend of $3.76 per share and has a dividend yield of 5.7%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. National Health Investors pays out 108.7% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

National Health Investors has a net margin of 38.56% compared to Sabra Healthcare REIT's net margin of 7.61%. National Health Investors' return on equity of 10.89% beat Sabra Healthcare REIT's return on equity.

Sabra Healthcare REIT has higher revenue and earnings than National Health Investors. National Health Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

Sabra Healthcare REIT presently has a consensus price target of $22.23, suggesting a potential upside of 16.03%. National Health Investors has a consensus price target of $82.25, suggesting a potential upside of 25.24%. Given National Health Investors' stronger consensus rating and higher probable upside, analysts plainly believe National Health Investors is more favorable than Sabra Healthcare REIT.

Sabra Healthcare REIT has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, National Health Investors has a beta of 0.49, suggesting that its share price is 51% less volatile than the broader market.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.3%. Omega Healthcare Investors pays an annual dividend of $2.72 per share and has a dividend yield of 5.9%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Omega Healthcare Investors pays out 97.1% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

In the previous week, Omega Healthcare Investors had 4 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 4 mentions for Omega Healthcare Investors and 0 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.79 beat Omega Healthcare Investors' score of 0.58 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Sabra Healthcare REIT currently has a consensus target price of $22.23, suggesting a potential upside of 16.03%. Omega Healthcare Investors has a consensus target price of $49.50, suggesting a potential upside of 8.27%. Given Sabra Healthcare REIT's stronger consensus rating and higher possible upside, analysts clearly believe Sabra Healthcare REIT is more favorable than Omega Healthcare Investors.

Omega Healthcare Investors has higher revenue and earnings than Sabra Healthcare REIT. Omega Healthcare Investors is trading at a lower price-to-earnings ratio than Sabra Healthcare REIT, indicating that it is currently the more affordable of the two stocks.

99.4% of Sabra Healthcare REIT shares are held by institutional investors. Comparatively, 65.3% of Omega Healthcare Investors shares are held by institutional investors. 1.1% of Sabra Healthcare REIT shares are held by company insiders. Comparatively, 1.7% of Omega Healthcare Investors shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Omega Healthcare Investors has a net margin of 66.96% compared to Sabra Healthcare REIT's net margin of 7.61%. Omega Healthcare Investors' return on equity of 15.76% beat Sabra Healthcare REIT's return on equity.

Sabra Healthcare REIT has a beta of 0.63, suggesting that its share price is 37% less volatile than the broader market. Comparatively, Omega Healthcare Investors has a beta of 0.53, suggesting that its share price is 47% less volatile than the broader market.

Sabra Healthcare REIT pays an annual dividend of $1.20 per share and has a dividend yield of 6.3%. Ventas pays an annual dividend of $2.08 per share and has a dividend yield of 2.5%. Sabra Healthcare REIT pays out 461.5% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas pays out 385.2% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future. Ventas has increased its dividend for 1 consecutive years.

Ventas has higher revenue and earnings than Sabra Healthcare REIT. Sabra Healthcare REIT is trading at a lower price-to-earnings ratio than Ventas, indicating that it is currently the more affordable of the two stocks.

In the previous week, Ventas had 3 more articles in the media than Sabra Healthcare REIT. MarketBeat recorded 3 mentions for Ventas and 0 mentions for Sabra Healthcare REIT. Sabra Healthcare REIT's average media sentiment score of 0.79 beat Ventas' score of 0.29 indicating that Sabra Healthcare REIT is being referred to more favorably in the media.

Sabra Healthcare REIT has a net margin of 7.61% compared to Ventas' net margin of 4.08%. Sabra Healthcare REIT's return on equity of 2.34% beat Ventas' return on equity.

Sabra Healthcare REIT has a beta of 0.63, meaning that its stock price is 37% less volatile than the broader market. Comparatively, Ventas has a beta of 0.72, meaning that its stock price is 28% less volatile than the broader market.

Sabra Healthcare REIT presently has a consensus price target of $22.23, suggesting a potential upside of 16.03%. Ventas has a consensus price target of $99.39, suggesting a potential upside of 18.27%. Given Ventas' stronger consensus rating and higher probable upside, analysts plainly believe Ventas is more favorable than Sabra Healthcare REIT.

99.4% of Sabra Healthcare REIT shares are owned by institutional investors. Comparatively, 94.2% of Ventas shares are owned by institutional investors. 1.1% of Sabra Healthcare REIT shares are owned by company insiders. Comparatively, 0.5% of Ventas shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.